Deyong Ye

1.0k total citations
54 papers, 766 citations indexed

About

Deyong Ye is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Deyong Ye has authored 54 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 15 papers in Organic Chemistry and 6 papers in Physiology. Recurrent topics in Deyong Ye's work include Sphingolipid Metabolism and Signaling (15 papers), Caveolin-1 and cellular processes (5 papers) and Computational Drug Discovery Methods (5 papers). Deyong Ye is often cited by papers focused on Sphingolipid Metabolism and Signaling (15 papers), Caveolin-1 and cellular processes (5 papers) and Computational Drug Discovery Methods (5 papers). Deyong Ye collaborates with scholars based in China, United States and Taiwan. Deyong Ye's co-authors include Lu Zhou, Yong Chu, Xian‐Cheng Jiang, Renxiao Wang, Ya Zhang, Ke Huang, Kaiqing Ma, Lulu Jiang, Peng‐Hui Wang and Shweta Varshney and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Deyong Ye

51 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deyong Ye China 17 444 249 95 56 49 54 766
Souvik Banerjee United States 16 432 1.0× 281 1.1× 50 0.5× 100 1.8× 92 1.9× 31 777
Luigi Margarucci Italy 17 373 0.8× 274 1.1× 45 0.5× 40 0.7× 40 0.8× 31 726
Rajiv Kumar Tonk India 12 381 0.9× 179 0.7× 59 0.6× 32 0.6× 88 1.8× 45 852
Youhong Hu China 16 262 0.6× 203 0.8× 125 1.3× 40 0.7× 71 1.4× 39 772
Michel Boisbrun France 19 337 0.8× 397 1.6× 63 0.7× 35 0.6× 78 1.6× 40 767
Athena Sudom United States 16 344 0.8× 210 0.8× 54 0.6× 37 0.7× 83 1.7× 21 809
Jiquan Zhang China 17 410 0.9× 371 1.5× 48 0.5× 35 0.6× 65 1.3× 72 952
José A. Gómez-Vidal Spain 16 301 0.7× 277 1.1× 114 1.2× 19 0.3× 66 1.3× 30 623
Tomomi Noguchi‐Yachide Japan 17 332 0.7× 208 0.8× 38 0.4× 33 0.6× 109 2.2× 36 631
Kunitomo Adachi Japan 16 936 2.1× 420 1.7× 64 0.7× 90 1.6× 65 1.3× 27 1.2k

Countries citing papers authored by Deyong Ye

Since Specialization
Citations

This map shows the geographic impact of Deyong Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deyong Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deyong Ye more than expected).

Fields of papers citing papers by Deyong Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deyong Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deyong Ye. The network helps show where Deyong Ye may publish in the future.

Co-authorship network of co-authors of Deyong Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Deyong Ye. A scholar is included among the top collaborators of Deyong Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deyong Ye. Deyong Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jintong, Wei Wang, Deyong Ye, et al.. (2024). Discovery of a novel thiophene carboxamide analogue as a highly potent and selective sphingomyelin synthase 2 inhibitor for dry eye disease therapy. Acta Pharmaceutica Sinica B. 15(1). 392–408.
2.
Bian, Jiang, Xin Lin, Chenyang Qiu, et al.. (2021). Discovery of styrylaniline derivatives as novel alpha-synuclein aggregates ligands. European Journal of Medicinal Chemistry. 226. 113887–113887. 10 indexed citations
3.
Zhang, Xiaodan, Lulu Jiang, Jian Li, et al.. (2020). Site-Selective Phosphoglycerate Mutase 1 Acetylation by a Small Molecule. ACS Chemical Biology. 15(3). 632–639. 15 indexed citations
4.
Chen, Yanfei, Jiang Bian, Lu-Lu Bu, et al.. (2020). Design, synthesis and identification of N, N-dibenzylcinnamamide (DBC) derivatives as novel ligands for α-synuclein fibrils by SPR evaluation system. Bioorganic & Medicinal Chemistry. 28(7). 115358–115358. 12 indexed citations
5.
Huang, Ke, Lulu Jiang, Ronghui Liang, et al.. (2019). Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment. European Journal of Medicinal Chemistry. 168. 45–57. 24 indexed citations
6.
Wang, Peng‐Hui, Lulu Jiang, Yang Cao, et al.. (2018). Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation. Bioorganic & Medicinal Chemistry. 26(8). 1961–1970. 20 indexed citations
7.
Lou, Bin, Qi Liu, Jiahui Hou, et al.. (2018). 2-Hydroxy-oleic acid does not activate sphingomyelin synthase activity. Journal of Biological Chemistry. 293(47). 18328–18336. 10 indexed citations
8.
Li, Yali, Bin Lou, Deyong Ye, et al.. (2018). Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor. European Journal of Medicinal Chemistry. 163. 864–882. 23 indexed citations
9.
Ye, Deyong, et al.. (2017). The discovery of novel benzothiazinones as highly selective non-ATP competitive glycogen synthase kinase 3β inhibitors for the treatment of ovarian cancer. European Journal of Medicinal Chemistry. 135. 370–381. 10 indexed citations
10.
Zhang, Peng, Shufen Li, Wenbo Lu, et al.. (2014). Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake. Bioorganic & Medicinal Chemistry Letters. 24(24). 5639–5643. 26 indexed citations
11.
Han, Liang, Mingming Liu, Deyong Ye, et al.. (2014). Tumor cell membrane-targeting pH-dependent electron donor-acceptor fluorescence systems with low background signals. Biomaterials. 35(9). 2952–2960. 17 indexed citations
12.
13.
Li, Xiaoxia, Shuang Hu, Ping Chen, et al.. (2014). Analysis of Fluorescent Ceramide and Sphingomyelin Analogs: A Novel Approach for in Vivo Monitoring of Sphingomyelin Synthase Activity. Lipids. 49(10). 1071–1079. 4 indexed citations
14.
Song, Wuhui, et al.. (2013). Tetrazole and triazole as bioisosteres of carboxylic acid: Discovery of diketo tetrazoles and diketo triazoles as anti-HCV agents. Bioorganic & Medicinal Chemistry Letters. 23(16). 4528–4531. 28 indexed citations
15.
Zhang, Peng, et al.. (2012). Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β). European Journal of Medicinal Chemistry. 61. 95–103. 32 indexed citations
16.
Ye, Deyong, Qian Shi, Chung-Hang Leung, et al.. (2012). Antitumor agents 294. Novel E-ring-modified camptothecin–4β-anilino-4′-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents. Bioorganic & Medicinal Chemistry. 20(14). 4489–4494. 9 indexed citations
17.
Li, Jianfeng, Lu Zhou, Deyong Ye, et al.. (2011). Choline‐Derivate‐Modified Nanoparticles for Brain‐Targeting Gene Delivery. Advanced Materials. 23(39). 4516–4520. 65 indexed citations
18.
Yeang, Calvin, Shweta Varshney, Renxiao Wang, et al.. (2008). The domain responsible for sphingomyelin synthase (SMS) activity. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1781(10). 610–617. 56 indexed citations
19.
Zhu, Li, et al.. (2007). Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists. European Journal of Medicinal Chemistry. 42(7). 977–984. 2 indexed citations
20.
Zhu, Li, Deyong Ye, & Yun Tang. (2006). Structure-based 3D-QSAR studies on thiazoles as 5-HT3 receptor antagonists. Journal of Molecular Modeling. 13(1). 121–131. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Souvik Banerjee Breakdown of academic impact, for papers by Luigi Margarucci Breakdown of academic impact, for papers by Rajiv Kumar Tonk Breakdown of academic impact, for papers by Youhong Hu Breakdown of academic impact, for papers by Michel Boisbrun Breakdown of academic impact, for papers by Athena Sudom Breakdown of academic impact, for papers by Jiquan Zhang Breakdown of academic impact, for papers by José A. Gómez-Vidal Breakdown of academic impact, for papers by Tomomi Noguchi‐Yachide Breakdown of academic impact, for papers by Kunitomo Adachi
Rankless by CCL
2026